Multiple sclerosis associated with pembrolizumab in a patient with non-small cell lung cancer

Marzia Romeo; Marina Chiara Garassino; Lucia Moiola; Giulia Galli; Gıancarlo Comı; Vittorio Martinelli; Massimo Filippi

doi:10.1007/s00415-019-09562-z

Related publications

Article2025

A Phase II study of GT103 in combination with pembrolizumab in refractory, metastatic non–small cell lung cancer

Hirva Mamdani, Ryan D. Gentzler, Lin Gu, Alberto Chiappori, Frank Weinberg, Greg Andrew Durm, Sarada Gurubhagavatula, Thomas E. Stinchcombe, James E. Herndon, Edward F. Patz, Jeffrey Clarke

Article2015

Aberrant DNA methylation in non-small cell lung cancer-associated fibroblasts

Miguel Vizoso, Marta Puig, F. Javier Carmona, María Maqueda, Adriana Velásquez, Antonio Gómez, Anna Labernadie, Roberto Lugo, Marta Gabasa, Luis G. Rigat-Brugarolas, Xavier Trepat, José Ramírez, Sebastián Morán, Enrique Vidal, Noemı́ Reguart, Alexandre Perera-Lluna, Manel Esteller, Jordi Alcaraz

Article2025

Perioperative pembrolizumab in early-stage non-small cell lung cancer (NSCLC): safety, efficacy, and exploratory biomarker analysis

C. G. Wood, Liliana Lyniv, James M Isaacs, Jacob M. Kaufman, Eziafa Oduah, Jeff Clarke, Jeffrey Crawford, Thomas E. Stinchcombe, Betty Tong, Xiaofei Wang, Lin Gu, Dennis A. Wigle, Konstantin H. Dragnev, Scott Antonia, Kent J. Weinhold, Neal Ready

Letter2007

ERCC1-Specific Immunostaining in Non–Small-Cell Lung Cancer

Ken A. Olaussen, Pierre Fouret, Guido Guido Kroemer

Article2018

Treating ALK-positive non-small cell lung cancer

Dimitrios C. Ziogas, Anna Tsiara, Georgios Tsironis, Maria Lykka, Michalis Liontos, Aristotelis Bamias, Meletios A Dimopoulos